Home › Therapeutic areas › Oncology › Esophageal Cancer
Esophageal Cancer (2 companies)
Companies with an active program in Esophageal Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| KAPA | Kairos Pharma | Oncology | 1 | Phase 2 | — | 13 |
| LEGN | Legend Biotech | Oncology Rare | 1 | Approved | $4.55B | 17 |
No companies match.